![Eric Karas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Karas
Corporate Officer/Principal chez
ARS Subsidiary, Inc.
Fortune : 73 056 $ au 31/08/2026
Profil
Eric Karas is currently Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. since 2022.
Formerly, Mr. Karas was Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. from 2018 to 2022.
Mr. Karas also served as Chief Commercial Officer at ARS Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 12 176 ( 0,01% ) | 73 056 $ | 31/08/2026 |
Postes actifs de Eric Karas
| Sociétés | Poste | Début |
|---|---|---|
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Corporate Officer/Principal | 01/04/2022 |
Anciens postes connus de Eric Karas
| Sociétés | Poste | Fin |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2026 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/03/2022 |
Formation de Eric Karas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Eli Broad College of Business
 Eli Broad College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
